← Back to headlines
Report Warns Weight Loss Drug Growth Poses Risk to Pharma Sector
A Deloitte report indicates that the pharmaceutical sector's growth, heavily fueled by weight loss drugs, is creating a 'bubble effect' and putting the industry at risk, with obesity assets now representing 25% of late-stage pipeline sales.
4 May, 10:45 — 4 May, 10:45
